KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables: 2017-2025

Historic Receivables for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $120.7 million.

  • Guardant Health's Receivables rose 29.68% to $120.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.0 million, marking a year-over-year increase of 27.84%. This contributed to the annual value of $113.7 million for FY2024, which is 21.32% up from last year.
  • As of Q3 2025, Guardant Health's Receivables stood at $120.7 million, which was down 9.97% from $134.1 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Receivables peaked at $134.1 million during Q2 2025, and registered a low of $65.8 million during Q1 2021.
  • For the 3-year period, Guardant Health's Receivables averaged around $104.2 million, with its median value being $94.4 million (2023).
  • As far as peak fluctuations go, Guardant Health's Receivables spiked by 88.95% in 2021, and later decreased by 9.29% in 2023.
  • Guardant Health's Receivables (Quarterly) stood at $103.4 million in 2021, then dropped by 0.67% to $102.7 million in 2022, then decreased by 8.74% to $93.7 million in 2023, then grew by 21.32% to $113.7 million in 2024, then increased by 29.68% to $120.7 million in 2025.
  • Its last three reported values are $120.7 million in Q3 2025, $134.1 million for Q2 2025, and $119.6 million during Q1 2025.